XAI Octagon Floating Rate & Alternative Income Term Trust Declares its Monthly Common Shares Distribution of $0.085 per Share
CHICAGO–(BUSINESS WIRE)–XAI Octagon Floating Rate & Alternative Income Term Trust (the “Trust”) has declared its regular monthly distribution... Read more.
MFS Announces Closed-End Fund Distributions
BOSTON–(BUSINESS WIRE)–MFS Investment Management® (MFS®) announced today monthly distributions of the following closed-end funds, all with declaration... Read more.
Ulta Beauty to Participate in Upcoming Investor Conference
BOLINGBROOK, Ill.–(BUSINESS WIRE)–Ulta Beauty, Inc. (NASDAQ: ULTA) today announced that Kiley Rawlins, vice president of investor relations, will present... Read more.
SiTime Completes Acquisition of Clock Products from Aura Semiconductor
SANTA CLARA, Calif.–(BUSINESS WIRE)–$SITM #Acquisition—SiTime Corporation (NASDAQ: SITM), the precision timing company, today announced it has... Read more.
E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study
ARLINGTON, Va.–(BUSINESS WIRE)–E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, based on the E*TRADE customer... Read more.
Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds
BOSTON–(BUSINESS WIRE)–Amundi US today announced the declaration of dividends for six Pioneer closed-end funds for December 2023. Ex-Date: December 11,... Read more.
Real-World Data Presented at SUO 2023 Show that Veracyte’s Decipher Genomic Classifier Identifies Patients Whose Prostate Cancer is Likely to Progress
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) announced that new data presented today at the 24th Annual Meeting of the Society... Read more.
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–$ATRA #CART—Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its... Read more.
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today... Read more.
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors
SAN DIEGO–(BUSINESS WIRE)–$MORF #MorphicHoldingInc–Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ: MORF)... Read more.